Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clostridium tetani is a motile, anaerobic, rod-shaped Gram-positive bacterium that forms highly resistant terminal spores, giving a distinct tennis racket/drumstick appearance under microscopy[1][4][5][7]. Spores are ubiquitous in soil and animal gastrointestinal tracts, surviving extreme conditions. When introduced via a wound in a low-oxygen environment, C. tetani can germinate, multiply, and produce the potent neurotoxin tetanospasmin, which blocks inhibitory neurotransmitter release in motor neurons—resulting in muscle spasms and the clinical syndrome of tetanus. Control and prevention of tetanus rely on good wound care, antibiotics, and vaccination against the tetanus toxin, not direct targeting of the bacterium as a molecular entity[1][4][5][7].
Antibiotics: Inhibit cell wall synthesis or disrupt bacterial DNA (elimination of C. tetani) Immune globulin: Passive immunization by neutralizing circulating toxin Vaccine: Stimulates adaptive immunity against tetanospasmin toxin
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridium tetani.